The charts, technical indicators, and signals here are generated live from Tech Trader, a fully autonomous trading system with no human intervention.
The second chart (if available) is a combination of Tech Trader with the Grok AI (from xAI) interpreting the chart and making trading decisions, including elaborate reports at the bottom explaining any given day.
Follow trades and activity on The Tech Trader Wall and Tech Trader + Grok Wall.
Daily Chart
(Technical analysis chart by Tech Trader)
Grok's Analysis - Grok 4
| 2025-10-24 | HOLD LONG |
| 2025-10-22 | HOLD LONG |
|
Summary: Hold long on DHR's confirmed uptrend with price above EMA/SMA post-earnings gap up, positive momentum despite minor pullback, targeting resistance near 252 amid no immediate catalysts....
|
|
| 2025-10-21 | BUY |
|
Summary: Enter long on DHR's strong post-earnings gap up in a confirmed uptrend with price above EMA/SMA, positive reaction despite 0% surprise, targeting resistance near 252 over weeks, justified re-entry soon after 10/16 exit due to new favorable earnings outcome and momentum shift....
|
|
| 2025-10-20 | CASH |
|
Summary: Stay in cash to avoid entering right before DHR's Q3 earnings on 10/21/2025, with technicals showing an uptrend but no high-confidence setup for a multi-week hold amid potential volatility, and past trade history indicating risks of post-earnings pullbacks without meeting hold-through criteria....
|
|
| 2025-10-17 | CASH |
|
Summary: Uptrend confirmed with price above EMA/SMA, but upcoming earnings on 10/21/2025 without meeting hold-through criteria prevent new long entry to avoid catalyst risk, while biotech nature bars shorting, so stay in cash awaiting post-earnings setup....
|
|
| 2025-10-16 | SOLD |
|
Summary: Exiting long DHR position near recent highs at 210.39 ahead of earnings on 10/21/2025 due to unmet surprise criteria, with price approaching resistance around 216 while uptrend remains intact but no major catalysts post-earnings to justify holding through volatility....
|
|
| 2025-10-15 | HOLD LONG |
|
Summary: Holding long on DHR's confirmed uptrend with price at 206.57 above EMA 201.26 and SMA 200.95, positive MACD 2.59, RSI 56 neutral, ongoing bounce from capitulation without breakdown, while planning exit near resistance 216 before earnings on 10/21/2025 due to unmet surprise criteria....
|
|
| 2025-10-14 | HOLD LONG |
|
Summary: Danaher's stock shows strong long-term fundamentals and recent support levels, making it a solid hold for potential upside....
|
|
| 2025-10-13 | HOLD LONG |
|
Summary: Holding long on DHR as the bounce from capitulation low continues with price at 205.32 above EMA/SMA around 200-201, positive MACD at 2.52, RSI 55 neutral, and no breakdown to supports like 182, while monitoring resistance at 216 and planning exit before earnings on 10/21/2025 due to unmet surprise criteria....
|
|
| 2025-10-10 | HOLD LONG |
|
Summary: Holding long on DHR as the bounce from capitulation low at $184.84 holds with price at 202.96 above key supports like 198-200 and EMA/SMA around 200, positive MACD at 2.56 signaling momentum, RSI at 52.8 neutral, and no breakdowns despite unclear trend with EMA slightly below SMA, while monitoring for resistance at 216 ahead of earnings on 10/21/2025....
|
|
| 2025-10-09 | HOLD LONG |
|
Summary: Holding long on DHR as the bounce from capitulation low at $184.84 continues with price above key supports around 198-200, positive MACD at 2.72 signaling upward momentum, RSI at 54 indicating balanced strength, and no immediate catalysts or breakdowns despite unclear trend with EMA slightly below SMA. Technicals prioritize here: EMA at 200.02 is below SMA at 200.34, but price remains above both, suggesting an unclear trend rather than a downtrend reversal—I'm not exiting solely on that, as the position was entered on capitulation strength. MACD is positive at 2.72 with the line above signal, and RSI at 53.76 avoids overbought territory, supporting continued momentum. Stochastic K at 75.02 and D at 75.50 show room for upside without exhaustion....
|
|
| 2025-10-08 | HOLD LONG |
|
Summary: Holding long on DHR as the bounce from capitulation low holds above key supports like 198-200 with positive MACD crossover and RSI at 55 signaling momentum, despite unclear trend from EMA below SMA, and earnings on 10/21/2025 still over a week away with no immediate catalysts found....
|
|
| 2025-10-07 | HOLD LONG |
|
Summary: Holding long on DHR as the breakout from capitulation low continues with price holding above rising supports around 196-200, positive momentum indicators like RSI at 59 and MACD improving, no compelling exit signals despite unclear trend from EMA slightly below SMA, and earnings still two weeks away....
|
|
| 2025-10-06 | HOLD LONG |
|
Summary: Holding long on DHR as the breakout momentum from capitulation low persists with price above key supports and pulling back mildly near $216 resistance on positive indicators, no strong exit signals yet ahead of earnings....
|
|
| 2025-10-03 | HOLD LONG |
|
Summary: Holding long on DHR as the breakout from capitulation low continues with price surging to near $216 resistance on high volume and positive momentum, no immediate exit signals despite unclear trend, targeting further upside before earnings....
|
|
| 2025-10-02 | HOLD LONG |
|
Summary: Holding long on DHR amid strong breakout momentum from capitulation low, price above EMA/SMA targeting $216 resistance, with positive news catalysts and no immediate exits warranted....
|
|
| 2025-10-01 | HOLD LONG |
|
Summary: Holding long on DHR after strong breakout to $211.20 on high volume from capitulation low, with price above EMA/SMA targeting $216 resistance, no immediate catalysts, and positive momentum overriding unclear trend signals....
|
|
| 2025-09-30 | HOLD LONG |
|
Summary: Holding long on DHR as the volume capitulation bounce from $181.35 low continues with price closing at $197.14 above EMA in a recovering trend, targeting resistance near $205-216, supported by RSI 53.8 and no invalidation after 3 trading days....
|
|
| 2025-09-29 | HOLD LONG |
|
Summary: Holding long on DHR after volume capitulation bounce from $181.35 low, with price at $186.06 showing early recovery in downtrend toward resistance at $205-216, supported by oversold RSI 38 and no invalidation yet. Today's close at $186.06 represents a modest rebound, aligning with historical patterns where DHR has bounced from oversold levels (e.g., RSI around 30-40) after high-volume selloffs, as seen in April 2025 when it dropped to $174.64 and recovered to $199 over weeks....
|
|
| 2025-09-26 | BUY |
|
Summary: Enter long on DHR's volume capitulation at oversold levels in a downtrend, with support near 182 holding and potential bounce to resistance around 205-216 over weeks, despite recent losses from early exits. RSI at 35 indicates oversold conditions, Stochastic K at 11.7 supports a bottom, and volume at 3.36M is moderate but flagged, with the low of 181.35 near the support level of 181.94 (strength 3, last tested in April 2025). This setup mirrors past oversold bounces in the trade history, like the July 18 entry at 190 that aimed for 205 resistance but was cut short by earnings—here, no immediate catalysts interfere....
|
|
| 2025-09-25 | CASH |
|
Summary: Stay in cash as DHR is in a clear downtrend without volume capitulation, precluding long entries, while its biotech and M&A exposure makes shorting too risky despite favorable technicals for a potential short....
|
|
| 2025-09-24 | CASH |
|
Summary: Stay in cash as DHR remains in a confirmed downtrend with EMA below SMA and price below both, no volume capitulation for a long entry, and shorting is avoided due to its biotech exposure risking sudden upside news....
|
|
| 2025-09-23 | CASH |
|
Summary: Stay in cash as DHR is in a clear downtrend with EMA below SMA and price below both, no recent volume capitulation to justify a long entry against the trend, and shorting is prohibited for this biotech-related stock given potential for sudden positive news spikes....
|
|
| 2025-09-22 | CASH |
|
Summary: Stay in cash as DHR is in a confirmed downtrend with price below both EMA and SMA, no volume capitulation for a long entry, and shorting is avoided due to its biotech exposure risking sudden upside from news....
|
|
| 2025-09-19 | CASH |
|
Summary: Stay in cash as DHR is in a downtrend with EMA below SMA and price below both, no volume capitulation for long entry, and shorting biotech stocks is avoided due to high spike risk on news....
|
|
| 2025-09-18 | CASH |
|
Summary: Stay in cash as DHR remains in a clear downtrend with price below EMA and SMA, no volume capitulation for a long entry, and shorting biotech stocks like DHR is avoided due to high spike risk on news....
|
|
| 2025-09-16 | CASH |
|
Summary: Stay in cash as DHR is in a downtrend with an unclear trend due to tightly rangebound EMA and SMA without volume capitulation, avoiding new entries per technical rules, while no high-conviction setups emerge from chart patterns or external factors....
|
|
| 2025-09-15 | CASH |
|
Summary: Stay in cash as DHR is in a confirmed downtrend with price below both EMA and SMA, no volume capitulation for a long entry, and as a biotech stock it's too risky to short despite the downtrend, with current levels near strong support around 187-189 avoiding poor entries....
|
|
| 2025-09-12 | CASH |
|
Summary: Stay in cash as DHR's technicals show an unclear trend with EMA slightly below SMA and tightly rangebound, price below both indicating potential downtrend without volume capitulation, recent support at 189.88 holding but no high-confidence setup for long or short entry given avoidance of shorts on biotech stocks and past failed longs in similar weakening conditions....
|
|
| 2025-09-11 | CASH |
|
Summary: Stay in cash as the trend is unclear with EMA and SMA tightly rangebound and frequently crossing, price below both without volume capitulation, and no high-confidence setup for entry despite proximity to support levels around 189-192....
|
|
| 2025-09-10 | CASH |
|
Summary: Stay in cash as DHR's trend is unclear with EMA slightly above SMA but price below both, no volume capitulation, and recent downtrend continuation without high-confidence reversal signals, targeting better entry opportunities near supports like 189.88 over the next few weeks....
|
|
| 2025-09-09 | CASH |
|
Summary: Stay in cash as the trend is unclear with price below both EMA and SMA despite EMA above SMA, no volume capitulation for a long entry in this setup, and DHR's biotech exposure prohibits shorting, while recent price action shows a pullback from resistance without strong bullish catalysts....
|
|
| 2025-09-08 | CASH |
|
Summary: Stay in cash as DHR's trend is unclear with price below both EMA and SMA despite EMA slightly above SMA, no volume capitulation, and recent pullback without high-confidence long or short setup amid rangebound action targeting support near 194-189 over the next few weeks....
|
|
| 2025-09-05 | CASH |
|
Summary: Stay in cash as the trend is unclear with EMA above SMA but price below both, frequent crossings in the past month without volume capitulation, and no high-confidence setup for entry despite oversold indicators like Stochastic K at 13, while avoiding shorts on this biotech-related stock....
|
|
| 2025-09-04 | CASH |
|
Summary: Stay in cash due to unclear trend with price below both EMA and SMA despite EMA above SMA, no volume capitulation, recent exit from long on 9/2 after failure to break resistance near 216, and no high-confidence setup for re-entry so soon without new bullish catalysts or trend confirmation....
|
|
| 2025-09-03 | CASH |
|
Summary: Stay in cash as the trend is unclear with EMA above SMA but price below both, no volume capitulation, and recent price weakness without a clear uptrend or high-confidence dip-buying opportunity, while avoiding shorts on this biotech-related stock....
|
|
| 2025-09-02 | SOLD |
|
Summary: Exit long on DHR as price has dipped below EMA in a weakening uptrend with no volume capitulation, recent failure to break resistance near 216, and momentum indicators like RSI at 48 showing loss of upside steam, targeting risk management ahead of potential further pullback to supports around 190-200 over the next few weeks....
|
|
| 2025-08-29 | HOLD LONG |
|
Summary: Hold long on DHR as the confirmed uptrend persists with price above EMA and SMA, recent pullback holding support near 204 while building towards 216 resistance, no imminent catalysts or volume capitulation, and positive momentum indicators supporting further upside over the next few weeks....
|
|
| 2025-08-28 | HOLD LONG |
|
Summary: Hold long on DHR as the uptrend remains confirmed with price above EMA and SMA, building momentum towards 216 resistance after holding support near 204, no volume capitulation or imminent catalysts, and positive sector trends....
|
|
| 2025-08-27 | HOLD LONG |
|
Summary: Hold long on DHR as the confirmed uptrend persists with price above EMA and SMA, momentum building towards 216 resistance after recent pullback support at 204, no imminent catalysts or volume capitulation, and positive healthcare sector trends from recent acquisitions....
|
|
| 2025-08-26 | HOLD LONG |
|
Summary: Hold long on DHR as the uptrend continues with price above EMA and SMA, recent momentum pushing towards 216 resistance, no volume capitulation or catalysts, and positive sector tailwinds....
|
|
| 2025-08-25 | HOLD LONG |
|
Summary: Hold long on DHR as the uptrend persists with price above EMA and SMA, positive momentum from recent breakout above 200-208 resistance targeting 216, no volume capitulation or imminent catalysts, and supportive fundamentals in life sciences sector....
|
|
| 2025-08-22 | HOLD LONG |
|
Summary: Hold long on DHR as the uptrend remains confirmed with price above EMA and SMA, recent breakout above prior resistance near 208 targeting next levels around 216, supported by positive momentum and no imminent catalysts. The current position entered 13 bars ago at $199.04 has appreciated to $212.4, meeting the minimum hold period while capturing a bigger multi-week move from support around $190-200, and simulation of similar setups in early 2025 (like the bounce from April lows) suggests high win rates with sustained rallies above key moving averages, avoiding past mistakes like early exits on temporary pullbacks seen in July trades....
|
|
| 2025-08-21 | HOLD LONG |
|
Summary: Hold long on DHR as the confirmed uptrend persists with price above EMA and SMA, pulling back from recent highs near 212 but holding above key supports around 200-202, targeting resistance at 216 with no imminent catalysts....
|
|
| 2025-08-20 | HOLD LONG |
|
Summary: Hold long on DHR as the uptrend continues with price above EMA and SMA, momentum building towards 216 resistance after recent highs above 210, no imminent earnings or reversals, maintaining the 8/5 entry at $199.04 now at 11 bars with current close at 211.08....
|
|
| 2025-08-19 | HOLD LONG |
|
Summary: Hold long on DHR as the uptrend persists with price above EMA and SMA, recent momentum pushing towards 216 resistance after breakout from 205, and no earnings or reversals imminent, maintaining the 8/5 entry at $199.04 now at 10 bars....
|
|
| 2025-08-18 | HOLD LONG |
|
Summary: Hold long on DHR as uptrend continues with price above EMA and SMA, recent breakout above 205 resistance holding with closes near 210, minimum 10-14 day hold from 8/5 entry ongoing at 9 bars, and no immediate earnings or trend reversals....
|
|
| 2025-08-15 | HOLD LONG |
|
Summary: Hold long on DHR as uptrend persists with price above EMA/SMA, recent breakout above 205 resistance holding firm, minimum 10-14 day hold from 8/5 entry not fully met yet, and no immediate catalysts or trend breakdowns....
|
|
| 2025-08-14 | HOLD LONG |
|
Summary: Hold long on DHR as uptrend remains with price above EMA/SMA, recent closes near 210 after breakout above 205 resistance, minimum hold period from 8/5 entry not yet met, and no immediate catalysts....
|
|
| 2025-08-13 | HOLD LONG |
|
Summary: Hold long on DHR as the uptrend persists with price above EMA and SMA, recent breakout above 205 resistance to 209 close, minimum 10-14 day hold from 8/5 entry at 199.04 not yet fully met, and no catalysts or trend invalidation....
|
|
| 2025-08-12 | HOLD LONG |
|
Summary: Hold long on DHR as uptrend continues with price above EMA/SMA, recent close at 205.34 nearing 205 resistance after bounce from 197 support, minimum 10-14 day hold from 8/5 entry not yet met, and no immediate catalysts....
|
|
| 2025-08-11 | HOLD LONG |
|
Summary: Hold long on DHR as uptrend persists with price above EMA/SMA, ongoing bounce from 197 support aiming for 205 resistance, no near-term catalysts, and minimum 10-14 day hold from 8/5 entry at $199.04 not yet fulfilled despite minor pullbacks. This aligns with the prior entry rationale, targeting resistance at $205.48, which has strong historical significance with 6 bounces. Volume on 8/11 was moderate at 1.68M, and indicators like RSI (51.71) suggest neutral momentum without overbought conditions, while SlowSTO_K (50.71) is building from oversold levels, supporting continued upside potential over weeks....
|
|
| 2025-08-08 | HOLD LONG |
|
Summary: Hold long on DHR as uptrend remains confirmed with price above EMA/SMA, recent bounce from 197 support targeting 205 resistance, no immediate catalysts like earnings (next on Oct 28, 2025), and minimum hold period of 10-14 days not yet met from 8/5 entry at $199.04 despite minor fluctuations....
|
|
| 2025-08-07 | HOLD LONG |
|
Summary: Hold long on DHR in confirmed uptrend with price above EMA/SMA, recent bounce from support near 197 targeting resistance at 205, no immediate catalysts, and minimum hold period not yet met despite minor pullback....
|
|
| 2025-08-06 | HOLD LONG |
|
Summary: Hold long on DHR despite pullback below EMA/SMA as position is only 1 day old requiring minimum 10-14 day hold, with unclear trend but potential bounce toward 205 resistance amid positive long-term sentiment and no immediate catalysts....
|
|
| 2025-08-05 | BUY |
|
Summary: Enter long on DHR's confirmed uptrend with price above EMA/SMA, recent bounce from pullback support around 197, positive momentum signals like power inflow, and targeting resistance near 205 over the next few weeks while monitoring for sustained strength....
|
|
| 2025-08-04 | CASH |
|
Summary: Stay in cash as the trend is unclear with EMA and SMA tightly rangebound without clear direction, avoiding new entries despite recent post-earnings momentum fading near resistance. Recent news from sources like Yahoo Finance and Benzinga highlights a key trading signal with the stock closing near highs at $193.11 last week, but softer Q2 profits and executive changes (CFO transition in Feb 2026, General Counsel departure Aug 25, 2025) add uncertainty without overriding technicals. Posts on X reflect long-term optimism on Danaher's business system and growth, but short-term sentiment is neutral. No volume capitulation flagged, and we're near support at $186 but below resistance at $205 with strong historical bounces there—simulating past setups like the July pullback shows risk of further downside or whipsaw, as our recent trades exited at losses due to similar weakening momentum. Cannot short due to Danaher's biotech exposure. Next earnings likely Q3 in October, no immediate catalysts within 3 days. Overall, better to wait for a clearer trend or dip in confirmed uptrend for a high-confidence long entry targeting $205+ over weeks.
|
|
| 2025-08-01 | CASH |
|
Summary: Stay in cash as the trend is unclear with EMA slightly above SMA but price below both, frequent price crossings without volume capitulation, and recent long trades resulted in losses amid weakening momentum post-earnings....
|
|
| 2025-07-31 | SOLD |
|
Summary: Exit long DHR position as the post-earnings uptrend has weakened with price below EMA, unclear trend from frequent crossings, softer Q2 profits, and pullback nearing support around $186 without volume capitulation, prioritizing risk management over minimum hold amid negative momentum....
|
|
| 2025-07-30 | HOLD LONG |
|
Summary: Hold long on DHR's sustained uptrend post-earnings with price above EMA/SMA, positive FY25 guidance, accelerating revenue consensus, and targeting resistance near $216 over the next few weeks without near-term catalysts....
|
|
| 2025-07-29 | HOLD LONG |
|
Summary: Hold long on DHR's continued post-earnings uptrend with price above EMA/SMA, recent breakout above $205 resistance, raised FY25 guidance, and no near-term catalysts, targeting further gains toward $216 over the coming weeks....
|
|
| 2025-07-28 | HOLD LONG |
|
Summary: Continue holding the long position in DHR amid a confirmed uptrend with positive post-earnings momentum from beaten estimates and raised guidance, targeting a breakout above $205 resistance while monitoring for sustained strength....
|
|
| 2025-07-25 | HOLD LONG |
|
Summary: Hold long on DHR's continued post-earnings strength with beaten estimates, raised guidance, uptrend intact above EMA/SMA, and breakout above $205 resistance, targeting further upside over weeks without immediate catalysts....
|
|
| 2025-07-24 | BUY |
|
Summary: Enter long on DHR's post-earnings momentum in a confirmed uptrend with beaten estimates, raised FY25 guidance, and no immediate catalysts, targeting potential breakout above $205 resistance over the next few weeks while monitoring for sustained closes above EMA/SMA....
|
|
| 2025-07-23 | CASH |
|
Summary: Stay in cash as the trend is unclear with EMA and SMA tightly rangebound, avoiding new entries post-earnings despite positive results, while waiting for a better dip after recent loss exit....
|
|
| 2025-07-22 | CASH |
|
Summary: Upcoming earnings on 7/23/2025 pose high risk of volatility, trend is unclear with EMA slightly above SMA but price below both and no volume capitulation, while oversold indicators tempt a bounce but recent early exit loss on similar pre-earnings setup advises staying sidelined for better post-catalyst entry....
|
|
| 2025-07-21 | SOLD |
|
Summary: Exit long DHR position early due to imminent Q2 earnings on 7/23/2025 with high risk of negative reaction based on historical post-earnings drops, despite oversold indicators and no clear downtrend invalidation yet, prioritizing catalyst avoidance over minimum hold period. ...
|
|
| 2025-07-18 | BUY |
|
Summary: Long DHR as it's oversold with RSI at 38, Stochastic K at 15, and close below Bollinger lower band near recent lows around 184-190, setting up a high-confidence bounce to resistance at 205 over the next few weeks with favorable risk/reward from current levels around 190....
|
|